Evidence map›Paper›PMID 32387061›Full record

GuidelineBulletin du cancer2020

COVID-19 and acute lymphoblastic leukemias of children and adolescents: First recommendations of the Leukemia committee of the French Society for the fight against Cancers and Leukemias in children and adolescents (SFCE).

André Baruchel, Yves Bertrand, Nicolas Boissel, Benoit Brethon, Stéphane Ducassou, Virginie Gandemer, Carine Halfon-Domenech, Thierry Leblanc, Guy Leverger, Gérard Michel and 7 more

Open access · greenAbstract readPractice Guideline
In one paragraph

Guideline in Bulletin du cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Observational
  7. Article
  8. A SARS-CoV-2-positive patient coincidentally diagnosed with B-ALL.Pediatrics international : official journal of the Japan Pediatric Society · 2021
    Article
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 1 country.

André BaruchelHôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France. Electronic address: andre.baruchel@aphp.fr.
Yves BertrandCHU de Lyon, institut d'hémato-oncologie pédiatrique, Lyon, France.
Nicolas BoisselHôpital Saint-Louis, AP-HP, Université de Paris, unité adolescents et jeunes adultes, Paris, France.
Benoit BrethonHôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
Stéphane DucassouGroupe hospitalier Pellegrin, unité d'hémato-oncologie pédiatrique, Bordeaux, France.
Virginie GandemerCHU de Rennes, service d'hémato-oncologie pédiatrique, Rennes, France.
Carine Halfon-DomenechCHU de Lyon, institut d'hémato-oncologie pédiatrique, Lyon, France.
Thierry LeblancHôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
Guy LevergerHôpital Armand-Trousseau AP-HP, Sorbonne université, service d'hémato-oncologie pédiatrique, Paris, France.
Gérard MichelCHU la Timone, service d'hématologie pédiatrique, Marseille, France.
Arnaud PetitHôpital Armand-Trousseau AP-HP, Sorbonne université, service d'hémato-oncologie pédiatrique, Paris, France.
Anne-France Ray-LunvenHôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
Pierre-Simon RohrlichCHU l'Archet, service d'hémato-oncologie pédiatrique, Nice, France.
Pascale SchneiderCHU Charles-Nicolle, service d'hématologie pédiatrique, Rouen, France.
Nicolas SirventCHU Arnaud-de-Villeneuve, service d'hématologie et oncologie pédiatrique, Montpellier, France.
Marion StrulluHôpital Universitaire Robert-Debré AP-HP, Université de Paris, service d'hémato-immunologie pédiatrique, Paris, France.
SFCE Leukemia Committee
Université Paris Cité · FRInstitut d’Hématologie et d’Oncologie Pédiatrique · FRSorbonne Université · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Rennes · FRHôpital Charles-Nicolle · FRHôpital de la Timone · FRHôpital Lapeyronie · FRHôpital Pellegrin · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the Leukemia Committee of the French Society for the fight against cancers and leukemias in children and adolescents (SFCE) to propose more specific recommendations, even if data for this population are still scarce. They may have to evolve according to the rapid evolution of knowledge on COVID-19.

Indexed as

AdolescentAntineoplastic Combined Chemotherapy ProtocolsAntiviral AgentsChildClinical Laboratory TechniquesCombined Modality TherapyComorbidityCoronavirus InfectionsCOVID-19COVID-19 TestingDisease ManagementDown SyndromeDrug InteractionsFebrile NeutropeniaFemaleGranulocyte Colony-Stimulating FactorAntiviral AgentsGranulocyte Colony-Stimulating FactorAcute lymphoblastic leukemia-children-adolescentsCOVID-19SARS-CoV-2

Identifiers

PMID32387061
PMCPMC7190519
OpenAlexW3021395543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.